Movie Theaters are in Big Financial Trouble

Core idea: “Box office is up” narrative vs. “theaters are in trouble”

The presenters argue that studios and media highlight headline box office success as proof that “theaters are back,” but this can mask a weaker underlying demand signal—specifically, “butts in seats” (attendance).

A key operational constraint is rising average ticket prices: ticket revenue can increase even if attendance declines. However, sustained attendance declines threaten theater survival long-term due to higher rents, higher consumer prices, and limited ability to further raise concession pricing.

In short: strong grosses can coexist with weakening attendance—and that combination isn’t sustainable for theaters.

Ticket-price inflation as the hidden variable

They point to average ticket price movement:

• ~$10 average ticket pre-COVID
• ~$16 average ticket in recent years

Their claim is that the market has shifted such that fewer people attend, while money totals still look strong—a pattern they argue cannot last.

Frameworks / playbooks mentioned (implicit through the analysis)

• Inflation-adjusted performance comparison Compare nominal grosses while accounting for inflation and market context.

• “Speed of revenue” / hold-rate model Use the rule of thumb that most films make ~70% of global box office in the first two weekends (typical range 50–70%) to estimate plausible final totals.

Key metrics, KPIs, and modeling targets (box office)

Spider-Man: Brand New Day (performance + plausible range)

Reported current totals

• International: ~$1.1B

Tracking / estimated final range (global)

• Most likely final: ~$2.5B to $2.8B
• “Lock” (presenter’s view): ~$2.5B
• Upper bound “mathematically possible”: up to ~$3.3B (requires unusually strong holds)

Domestic estimate (scenario-based vs. Endgame)

• If it keeps ~6% better than Endgame at the same release point: domestic end-run could be about ~$900M–$915M

• If domestic lands around $900M–$1.0B, reaching $3B globally becomes less likely.

Revenue-share model used

• If the film were to “double” (presenter says unlikely), it could push toward the high end.
• A “70% first two weekends” scenario supports an upper plausible global max.
• A lower-end “50–70%” hold scenario implies a lower plausible final.

Endgame comparison (benchmark only)

The presenter says Brand New Day is doing about ~6% better than Endgame at the same point in release (nominally), but this does not guarantee more seats were sold once inflation and attendance are accounted for.

Avengers: Doomsday (budget break-even logic)

Early indicator

• Combined budget + marketing for Doomsday is north of $1B spent on it alone.

Implied break-even target

• Needs roughly ~$2.5B to break even (presenter’s estimate).

Expected milestones

• “Guaranteed” global base case: ~$1.5B
• “On the table”: ~$2B

Profitability view

• The presenter doubts profit unless it performs significantly above expectations.

Concrete examples / case studies referenced

• Avatar “done?” debate Used to illustrate franchise risk: the presenter argues “value loss” and declining audience are difficult to sustain even when total gross looks impressive.

• Odyssey (IMAX/70mm strategy) Presented as an execution example: a heavy premium-format push (IMAX + 70mm) where scarcity can drive resale prices (example cited: tickets sold for $500 on eBay). Critique: this strategy can raise revenue per attendee (as a ticket-price proxy) and inflate impressions of demand even if total attendance isn’t as high as headline totals suggest.

  • Opening-weekend mix claim:
    • Over 50% from premium screens
    • ~25% from IMAX alone

• Doctor Strange and the Multiverse of Madness Used as a cautionary tale:

  • Global opening mentioned: ~$450M
  • Then it “fell off a cliff,” attributed to weak audience retention / negative word-of-mouth.

Actionable recommendations / operational implications

For studios / distributors

• Don’t rely only on nominal box office to gauge health.
• Track attendance/seat counts and format mix alongside gross revenue.
• Plan for theater sustainability, not just short-term theatrical profit:
  • Expect longer lulls after big releases, while operating costs (rents, consumer pricing pressure) keep rising.

For marketing strategy

• Premium-format marketing (IMAX/70mm) can increase revenue per attendee, but may conceal weaker broad audience penetration.
• “Narrative marketing” (“Hollywood is back”) can help internally for incentives, but if it ignores attendance decline, it raises long-term risk.

Overall conclusion: why theaters may still be “in big financial trouble”

The presenters’ central thesis:

• Studios can be profitable theatrically (and often more profitable through post-theatrical windows like home video and merchandising),
• while theaters face structural headwinds: attendance sensitivity to pricing, rising operating costs, and inconsistent downstream demand between marquee releases.

They argue that unless the industry rebuilds sustainable attendance volume, theater closures will continue—even if some blockbusters post very large gross numbers.

Presenters / sources

• RealLifeFakeWizard
• Odin (from OMB Reviews)